Kazutoshi Yukawa
Overview
Explore the profile of Kazutoshi Yukawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida Y, Omoto T, Kohno H, Tokunaga T, Kuranobu T, Yukawa K, et al.
Mod Rheumatol
. 2020 Aug;
31(3):643-648.
PMID: 32815450
Objectives: Lupus enteritis (LE) is a rare but well-known gastrointestinal manifestation of systemic lupus erythematosus (SLE). This study was conducted to identify prognostic factors associated with poor responses in patients...
2.
Sato M, Yoshida Y, Sugimoto T, Kishimoto S, Omoto T, Watanabe H, et al.
Mod Rheumatol Case Rep
. 2020 Aug;
5(1):130-136.
PMID: 32791887
A 33-year-old male with a history of bronchial asthma and allergic rhinitis was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) eight years ago. The diagnosis was based on the presence...
3.
Kuranobu T, Mokuda S, Oi K, Tokunaga T, Yukawa K, Kohno H, et al.
Pathobiology
. 2020 Mar;
87(3):198-207.
PMID: 32126552
Objective: Activin A is known to be highly expressed in rheumatoid synovium. In the present study, we investigated the effect of inflammatory cytokines on activin A production and its role...
4.
Tokunaga T, Mokuda S, Kohno H, Yukawa K, Kuranobu T, Oi K, et al.
Int J Mol Sci
. 2020 Jan;
21(3).
PMID: 31991837
Osteoclasts are multinucleated giant cells responsible for bone resorption. Various mediators involved in osteoclast differentiation have been investigated as possible therapeutic targets for osteoporosis and rheumatoid arthritis (RA). Although transforming...
5.
Yukawa K, Mokuda S, Kohno H, Oi K, Kuranobu T, Tokunaga T, et al.
Clin Exp Rheumatol
. 2020 Jan;
38(5):956-963.
PMID: 31969227
Objectives: This study aimed to identify therapeutic predictors of abatacept (ABT) treatment in rheumatoid arthritis (RA) in vitro and in patients. Methods: T cell cytokine, monokine, and chemokine levels in...
6.
Yoshida Y, Kondo T, Hosokawa Y, Oki K, Yukawa K, Araki K, et al.
J Clin Rheumatol
. 2019 Feb;
27(8S):S571-S573.
PMID: 30724757
No abstract available.
7.
Yukawa K, Nagamoto Y, Watanabe H, Funaki M, Iwahashi M, Yamana J, et al.
J Clin Rheumatol
. 2018 Apr;
24(7):355-360.
PMID: 29664819
Background/objectives: Immunosuppressant medications (ISPs) increase the occurrence of Pneumocystis jirovecii pneumonia (PCP) in rheumatoid arthritis (RA) patients. The prophylactic administration of trimethoprim/sulfamethoxazole (TMP/SMX) for PCP is effective but has serious...